 Clinical implications pathophysiologic changes midlife hypertensive patient hypertension decrease cardiac output stroke volume diminished beta-adrenergic responsiveness parallel vascular resistance increases vascular hypertrophy addition hypertension alpha-adrenergic responsiveness Aging hypertension increase plasma cholesterol insulin values alterations cholesterol insulin levels middle-aged patients hypertension alpha-Adrenergic-blocking agents positive effect lipids insulin resistance shift enhanced alpha-adrenergic responsiveness fact vasodilators exercise performance favor use alpha-blockers first drug middle-aged patients hypertension Blood pressure paramount goal compounds efficacious individual patient